These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36094619)

  • 1. The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia.
    Kaar SJ; Angelescu I; Nour MM; Marques TR; Sharman A; Sajjala A; Hutchison J; McGuire P; Large C; Howes OD
    Psychopharmacology (Berl); 2022 Oct; 239(10):3313-3323. PubMed ID: 36094619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [
    Angelescu I; Kaar SJ; Marques TR; Borgan F; Veronesse M; Sharman A; Sajjala A; Deakin B; Hutchison J; Large C; Howes OD
    J Psychopharmacol; 2022 Sep; 36(9):1061-1069. PubMed ID: 36164687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic Dysfunction.
    Kaar SJ; Nottage JF; Angelescu I; Marques TR; Howes OD
    Clin EEG Neurosci; 2024 Mar; 55(2):203-213. PubMed ID: 36591873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ventral striatal functional connectivity in patients with schizophrenia during reward anticipation.
    Carruzzo F; Kaiser S; Tobler PN; Kirschner M; Simon JJ
    Neuroimage Clin; 2022; 33():102944. PubMed ID: 35078045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium channel modulators and schizophrenia: an overview of investigational drugs.
    Musselman M; Huynh E; Kelshikar R; Lee E; Malik M; Faden J
    Expert Opin Investig Drugs; 2023; 32(6):471-477. PubMed ID: 37247333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal Response to Reward Anticipation as a Biomarker for Schizophrenia and Negative Symptoms: Effects, Test-Retest Reliability, and Stability Across Sites.
    Carruzzo F; Kaliuzhna M; Kuenzi N; Geffen T; Katthagen T; Schlagenhauf F; Kaiser S
    Schizophr Bull; 2024 Jul; 50(4):733-746. PubMed ID: 38641344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventral Striatal Dysfunction and Symptom Expression in Individuals With Schizotypal Personality Traits and Early Psychosis.
    Kirschner M; Hager OM; Muff L; Bischof M; Hartmann-Riemer MN; Kluge A; Habermeyer B; Seifritz E; Tobler PN; Kaiser S
    Schizophr Bull; 2018 Jan; 44(1):147-157. PubMed ID: 27798223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia.
    Kirschner M; Hager OM; Bischof M; Hartmann MN; Kluge A; Seifritz E; Tobler PN; Kaiser S
    J Psychiatry Neurosci; 2016 Apr; 41(3):152-61. PubMed ID: 26395814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [
    Shatalina E; Ashok AH; Wall MB; Nour MM; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Neuroimage Clin; 2023; 39():103481. PubMed ID: 37517175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator.
    Parekh PK; Sidor MM; Gillman A; Becker-Krail D; Bettelini L; Arban R; Alvaro GS; Zambello E; Mutinelli C; Huang Y; Large CH; McClung CA
    Neuropsychopharmacology; 2018 Jan; 43(2):435-444. PubMed ID: 28857068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients.
    Esslinger C; Englisch S; Inta D; Rausch F; Schirmbeck F; Mier D; Kirsch P; Meyer-Lindenberg A; Zink M
    Schizophr Res; 2012 Sep; 140(1-3):114-21. PubMed ID: 22784688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine Suppresses the Ventral Striatal Response to Reward Anticipation: A Cross-Species Translational Neuroimaging Study.
    Francois J; Grimm O; Schwarz AJ; Schweiger J; Haller L; Risterucci C; Böhringer A; Zang Z; Tost H; Gilmour G; Meyer-Lindenberg A
    Neuropsychopharmacology; 2016 Apr; 41(5):1386-94. PubMed ID: 26388147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients.
    de Leeuw M; Kahn RS; Vink M
    Schizophr Bull; 2015 Jan; 41(1):94-103. PubMed ID: 25368371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Striatal Response to Reward Anticipation Linked to Hippocampal Glutamate Levels.
    Bossong MG; Wilson R; Appiah-Kusi E; McGuire P; Bhattacharyya S
    Int J Neuropsychopharmacol; 2018 Jul; 21(7):623-630. PubMed ID: 29444252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of Kv3 voltage-gated potassium channels regulates fear discrimination and expression in a response-dependent manner.
    Stubbendorff C; Hale E; Day HLL; Smith J; Alvaro GS; Large CH; Stevenson CW
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110829. PubMed ID: 37451593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventral Striatal Activation During Reward Processing in Psychosis: A Neurofunctional Meta-Analysis.
    Radua J; Schmidt A; Borgwardt S; Heinz A; Schlagenhauf F; McGuire P; Fusar-Poli P
    JAMA Psychiatry; 2015 Dec; 72(12):1243-51. PubMed ID: 26558708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reward Anticipation in Ventral Striatum and Individual Sensitivity to Reward: A Pilot Study of a Child-Friendly fMRI Task.
    van Hulst BM; de Zeeuw P; Lupas K; Bos DJ; Neggers SF; Durston S
    PLoS One; 2015; 10(11):e0142413. PubMed ID: 26599542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional Parvalbumin Neurons in Schizophrenia and the Pathway to the Clinical Application of Kv3 Channel Modulators.
    Yanagi M; Hashimoto M
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the reward system by antipsychotic treatment.
    Juckel G
    Dialogues Clin Neurosci; 2016 Mar; 18(1):109-14. PubMed ID: 27069385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K
    Boddum K; Hougaard C; Xiao-Ying Lin J; von Schoubye NL; Jensen HS; Grunnet M; Jespersen T
    Neuropharmacology; 2017 May; 118():102-112. PubMed ID: 28242439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.